BALCHEM CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 143.5 USD | -0.19% |
|
-3.60% | -3.24% |
| Mar. 29 | Balchem Corporation Announces Management Changes | CI |
| Mar. 12 | Balchem Insider Sold Shares Worth $840,985, According to a Recent SEC Filing | MT |
Presentation Operator MessageOperator (Operator)Greetings, and welcome to Balchem Corporation'...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Sector
Specialty Chemicals
Calendar
2024-04-25
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
143.8
USD
Average target price
154.3
USD
Spread / Average Target
+7.32%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.24% | 4.64B | |
| +10.65% | 62.69B | |
| -4.60% | 45.57B | |
| +12.00% | 39.23B | |
| +18.36% | 26.87B | |
| +1.32% | 17.72B | |
| +3.97% | 15.27B | |
| -30.64% | 13.94B | |
| -21.85% | 13.44B | |
| -23.55% | 13.15B |
- Stock Market
- Equities
- BCPC Stock
- News Balchem Corporation
- Transcript : Balchem Corporation, Q3 2021 Earnings Call, Oct 29, 2021
